Currently approved GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Bydureon BCise)
Its just not a cure for obesity
Regular follow-ups help ensure the treatment is working effectively and safely for you
Additional research has evaluated the relationship between growth hormone signaling and body composition, metabolism, tissue maintenance, cellular adaptation, and healthy aging
With growing interest, healthcare professionals are exploring methods to cope with the demand, sometimes prescribing other semaglutide brands like Ozempic and Rybelsus off-label (using an FDA-approved drug for a different purpose)